Hydroxycarteolol
Systematic (IUPAC) name | |
---|---|
8-Hydroxy-5-{2-hydroxy-3-[(2-methyl-2-propanyl)amino]propoxy}-3,4-dihydro-2(1H)-quinolinone | |
Clinical data | |
Identifiers | |
39099-98-4 | |
None | |
PubChem | CID 124688 |
ChemSpider | 111020 |
Synonyms | 8-Hydroxycarteolol |
Chemical data | |
Formula | C16H24N2O4 |
308.37 g/mol | |
SMILES
| |
|
Hydroxycarteolol is a beta blocker and metabolite of carteolol.[1][2]
References
- ā Igarashi H, Katsuta Y, Sawa K, Nakazato Y, Kawasaki T. (Apr 1990). "A comparison of the opacifying effects of carteolol.HCl and 8-hydroxycarteolol.HCl in the isolated porcine cornea". Fundam Appl Toxicol 14 (3): 554ā559. doi:10.1093/toxsci/14.3.554. PMID 2340982.
- ā Jasper JR, Michel MC, Insel PA (1990). "The beta-adrenoceptor antagonist carteolol and its metabolite 8-hydroxycarteolol have different intrinsic sympathomimetic activities". Br J Clin Pharmacol 30 (Suppl 1): 109Sā111S. doi:10.1111/j.1365-2125.1990.tb05477.x. PMC 1368107. PMID 2176514.